Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
11.71
+0.41 (3.63%)
At close: Jan 22, 2026, 4:00 PM EST
11.60
-0.11 (-0.94%)
After-hours: Jan 22, 2026, 5:24 PM EST
Entrada Therapeutics Employees
Entrada Therapeutics had 183 employees as of December 31, 2024. The number of employees increased by 24 or 15.09% compared to the previous year.
Employees
183
Change (1Y)
24
Growth (1Y)
15.09%
Revenue / Employee
$336,175
Profits / Employee
-$565,328
Market Cap
419.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 183 | 24 | 15.09% |
| Dec 31, 2023 | 159 | 29 | 22.31% |
| Dec 31, 2022 | 130 | 16 | 14.04% |
| Dec 31, 2021 | 114 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Rocket Pharmaceuticals | 299 |
| Lineage Cell Therapeutics | 77 |
| Assembly Biosciences | 73 |
| PureTech Health | 56 |
| Cybin | 50 |
| Zura Bio | 30 |
| DiaMedica Therapeutics | 28 |
TRDA News
- 7 days ago - Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 14 days ago - Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases - GlobeNewsWire
- 5 weeks ago - Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha
- 2 months ago - Entrada Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Entrada Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Entrada Therapeutics, Inc. - Special Call - Seeking Alpha